Financial Counselors Inc Blueprint Medicines Corp Transaction History

Financial Counselors Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$54.1 - $110.08 $109,282 - $222,361	-2,020 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$94.25 - $115.99 $942 - $1,159	10 Added 0.5%	2,020 $216,000
Q3 2021 Oct 26, 2021	BUY	$80.98 - $109.47 $162,769 - $220,034	2,010 New	2,010 $207,000
Q2 2021 Aug 03, 2021	SELL	$82.78 - $101.0 $190,394 - $232,300	-2,300 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$90.71 - $108.28 $38,098 - $45,477	-420 Reduced 15.44%	2,300 $224,000
Q4 2020 Feb 10, 2021	SELL	$92.08 - $124.48 $19,336 - $26,140	-210 Reduced 7.17%	2,720 $305,000
Q3 2020 Nov 16, 2020	BUY	$66.45 - $92.7 $5,980 - $8,343	90 Added 3.17%	2,930 $272,000
Q2 2020 Aug 07, 2020	SELL	$57.09 - $79.27 $96,482 - $133,966	-1,690 Reduced 37.31%	2,840 $222,000
Q1 2020 Apr 23, 2020	BUY	$48.11 - $82.22 $47,147 - $80,575	980 Added 27.61%	4,530 $265,000
Q4 2019 Jan 31, 2020	BUY	$66.73 - $82.59 $2,001 - $2,477	30 Added 0.85%	3,550 $284,000
Q3 2019 Nov 08, 2019	BUY	$72.9 - $101.41 $34,263 - $47,662	470 Added 15.41%	3,520 $259,000
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $12,501 - $16,626	170 Added 5.9%	3,050 $288,000
Q1 2019 May 10, 2019	BUY	$48.7 - $86.6 $140,256 - $249,407	2,880 New	2,880 $231,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.38B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Counselors Inc with notifications on news.